These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7027252)

  • 41. Suppression of contact sensitivity by IgG1 antihapten antibody. IgG1 antihapten antibody suppresses migration inhibitory factor production by lymph node cells.
    Katayama I; Nishioka K
    Int Arch Allergy Appl Immunol; 1983; 70(2):178-84. PubMed ID: 6337109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of tunicamycin on the molecular heterogeneity of guinea pig migration inhibitory factor.
    Remold HG; Mednis AD
    Cell Immunol; 1982 Jan; 66(1):171-9. PubMed ID: 7044563
    [No Abstract]   [Full Text] [Related]  

  • 43. Migration inhibitory factor.
    Remold HG; Mednis AD
    Methods Enzymol; 1985; 116():379-94. PubMed ID: 3911018
    [No Abstract]   [Full Text] [Related]  

  • 44. Macrophage migration inhibitory factor (MIF) produced by a human T cell hybridoma clone.
    Hirose S; Ooki S; Higuchi M; Osawa T
    Microbiol Immunol; 1991; 35(3):235-45. PubMed ID: 1870440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophage migration inhibitory factor (MIF) produced by a human T cell hybridoma clone.
    Oki S; Hirose S; Higuchi M; Osawa T
    Lymphokine Cytokine Res; 1991 Aug; 10(4):273-80. PubMed ID: 1932371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissociation of MIF activity and in vitro lymphocyte transformation in the development of experimental allergic thyroiditis in guinea pigs.
    Hiramine C; Hojo K
    Tohoku J Exp Med; 1976 Feb; 118(2):137-43. PubMed ID: 790649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Affinity purification of macrophage migration inhibitory factor/glycosylation inhibiting factor (MIF/GIF) from bovine brain by using a peptide ligand derived from a novel serpin.
    Nishibori M; Nakaya N; Mori S; Kawabata M; Tahara A; Saeki K
    Jpn J Pharmacol; 1996 Jul; 71(3):259-62. PubMed ID: 8854209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of an antibody against guinea pig MIF. I. Specificity of the anti-MIF antibody.
    Onozaki K; Haga S; Miura K; Ichikawa M; Hashimoto T
    Cell Immunol; 1979 Dec; 48(2):258-66. PubMed ID: 389441
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of the concentration of inducing agent on the output of lymphokines in the guinea pig.
    Ford WH; Ashworth LA; Inder S
    Eur J Immunol; 1976 Feb; 6(2):135-8. PubMed ID: 786697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of macrophage migration by normal guinea pig intestinal secretions.
    Gadol N; Waldman RH; Clem LW
    Proc Soc Exp Biol Med; 1976 Apr; 151(4):654-8. PubMed ID: 772687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole.
    Daniels JC; Warren KS; David JR
    J Immunol; 1975 Nov; 115(5):1414-21. PubMed ID: 51891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production of migration inhibitory factor and lymphotoxin by non-T cells.
    Bloom BR; Stoner G; Gaffney J; Shevach E; Green I
    Eur J Immunol; 1975 Mar; 5(3):218-20. PubMed ID: 789088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A simple method for the production of migration inhibitory factor by concanavalin A - stimulated lymphocytes.
    Pick E; Kotkes P
    J Immunol Methods; 1977; 14(2):141-6. PubMed ID: 320265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrophage migration inhibitory factor: isolation from bovine brain.
    Cherepkova OA; Lyutova EM; Gurvits BY
    Biochemistry (Mosc); 2006 Jan; 71(1):73-8. PubMed ID: 16457622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure.
    Nishihira J; Kuriyama T; Nishino H; Ishibashi T; Sakai M; Nishi S
    Biochem Mol Biol Int; 1993 Dec; 31(5):841-50. PubMed ID: 8136702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Partial purification and characterization of a human lymphokine which induces antileishmanial activity in mouse macrophages.
    Buchmuller Y; Weiser WY; Remold HG
    Cell Immunol; 1985 Jan; 90(1):242-50. PubMed ID: 3881189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction.
    Rosengren E; Bucala R; Aman P; Jacobsson L; Odh G; Metz CN; Rorsman H
    Mol Med; 1996 Jan; 2(1):143-9. PubMed ID: 8900542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The biochemistry and in vitro activity of soluble factors of activated lymphocytes.
    Sorg C
    Mol Cell Biochem; 1979 Dec; 28(1-3):149-67. PubMed ID: 393992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. III. Generation of monoclonal antibody specific for human MIF.
    Fahlbusch B; Schumann I
    Biomed Biochim Acta; 1987; 46(5):397-406. PubMed ID: 3311040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fractionation of murine macrophage inhibitory factor into two distinct species.
    Bout D; Kühner AL; Klimetzek V; Remold HG; David JR
    Cell Immunol; 1981 Sep; 63(1):198-202. PubMed ID: 7023702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.